CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2013	Aug. 31, 2012	Aug. 31, 2013	Aug. 31, 2012
Revenue	$ 12,329	$ 12,329	$ 36,988	$ 36,988
Operating expenses
Selling, general and administrative	207,753	231,953	626,092	649,454
Research and development	95,418	53,694	216,590	276,324
Stock-based compensation	52,945	105,446	175,866	226,162
Total operating expenses	356,116	391,093	1,018,548	1,151,940
Loss from operations	(343,787)	(378,764)	(981,560)	(1,114,952)
Other income (expense)
Interest expense	(707)	(762)	(2,058)	(7,424)
Change in fair value of derivative liability	(902)	60,562	(11,342)	104,526
Gain on disposition of equipment	0	1,500	0	1,500
Interest income	36	106	171	593
Total other income (expense)	(1,573)	61,406	(13,229)	99,195
Net loss	(345,360)	(317,358)	(994,789)	(1,015,757)
Less net loss attributable to the noncontrolling interests	(42,264)	(22,771)	(91,211)	(71,841)
Net loss attributable to MultiCell Technologies, Inc.	$ (303,096)	$ (294,587)	$ (903,578)	$ (943,916)
Basic and Diluted Loss Per Common Share (in dollars per share)	$ (0.00014)	$ (0.00028)	$ (0.00052)	$ (0.00099)
Basic and Diluted Weighted-Average Common Shares Outstanding (in shares)	2,105,332,608	1,065,058,664	1,730,465,999	957,413,780